Polymerizable resins containing a 1,3,5-hexahydro-1,3,5-triazine moiety, methods of making, and dental compositions containing the same

US9944611B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-9944611-B2
Application numberUS-201615352772-A
CountryUS
Kind codeB2
Filing dateNov 16, 2016
Priority dateOct 30, 2013
Publication dateApr 17, 2018
Grant dateApr 17, 2018

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

Disclosed herein are methods of making polymerizable resins containing a 1,3,5-hexahydro-1,3,5-triazine moiety and dental compositions comprising such novel hydrolytically-stable, polymerizable resins derived from a 1,3,5-hexahydro-1,3,5-triazine.

First claim

Opening claim text (preview).

I claim: 1. A method of forming a hydrolytically-stable, water-soluble polymerizable resin containing a 1,3,5-hexahydro-1,3,5-triazine moiety, the method comprising: reacting the 1,3,5-hexahydro-1,3,5-triazine moiety in the presence of a Michael donor under conditions selected to yield mono-substituted and di-substituted 1,3,5-hexahydro-1,3,5-triazine resin present in a combined amount that is greater than a combined amount of tri-substituted 1,3,5-hexahydro-1,3,5-triazine and unreacted 1,3,5-hexahydro-1,3,5-triazine moiety; wherein the Michael donor is selected from the group consisting of a secondary amine and a thiol and the Michael donor is hydroxyl-terminated. 2. The method of claim 1 , wherein the mono- and di-substituted 1,3,5-hexahydro-1,3,5-triazine resins, respectively, have the following general formula: wherein X is H or CH 3 , R is CH 2 CH 2 —Y, Y is —SR′, —NR′R or —NR′″; R′ and R″ independently or the same are linear or branched linear alkyl having 1 to 18 carbon atoms with or without functional groups, and R′″ is a cyclic alkyl having 2 to 18 carbon atoms or a heterocyclic compound. 3. The method of claim 2 , wherein R′ and R″ are of the general form R′(R″)—Z m , wherein m=1-3 and Z═—OH, —SH, —COOH, COOR′(R″)(R′″), —OPO(OH) 2 , —OPO(OR′)(OH), —PO(OH) 2 , —PO(OR′)(OH), —OSO 2 (OH), aromatics, or substituted aromatics. 4. The method of claim 1 , wherein the hydrolytically-stable, water-soluble polymerizable resin comprises at least one acrylamide group. 5. The method of claim 1 , wherein the hydrolytically-stable, water-soluble polymerizable resin comprises at least one inorganic acidic group. 6. The method of claim 1 , wherein the hydrolytically-stable, water-soluble polymerizable resin comprises at least one imidazolium group. 7. The method of claim 1 , wherein the hydrolytically-stable, water-soluble polymerizable resin comprises at least one imidazole group. 8. The method of claim 1 further comprising adding a phosphoric acid to the Michael donor of the mono- and di-substituted 1,3,5-hexahydro-1,3,5-triazine resin after the step of reacting the 1,3,5-hexahydro-1,3,5-triazine moiety with the Michael donor. 9. A method of forming a hydrolytically-stable, water-soluble polymerizable resin containing a 1,3,5-hexahydro-1,3,5-triazine moiety, the method comprising: reacting the 1,3,5-hexahydro-1,3,5-triazine moiety in the presence of a Michael donor under conditions selected to yield mono-substituted and di-substituted 1,3,5-hexahydro-1,3,5-triazine resin present in a combined amount that is greater than a combined amount of tri-substituted 1,3,5-hexahydro-1,3,5-triazine and unreacted 1,3,5-hexahydro-1,3,5-triazine moiety; wherein the Michael donor is imidazole. 10. The method of claim 9 further comprising converting the imidazole of the mono- and di-substituted 1,3,5-hexahydro-1,3,5-triazine resin to an imidazolium after the step of reacting the 1,3,5-hexahydro-1,3,5-triazine moiety with the Michael donor. 11. The method of claim 10 , wherein the step of converting the imidazole of the mono- and di-substituted 1,3,5-hexahydro-1,3,5-triazine resin to an imidazolium comprises reacting the mono- and di-substituted 1,3,5-hexahydro-1,3,5-triazine resin with bromohexane. 12. The method of claim 10 , wherein the step of converting the imidazole of the mono- and di-substituted 1,3,5-hexahydro-1,3,5-triazine resin to an imidazolium comprises reacting the mono- and di-substituted 1,3,5-hexahydro-1,3,5-triazine resin with bromododecane. 13. A method of forming a hydrolytically-stable, water-soluble polymerizable resin containing a 1,3,5-hexahydro-1,3,5-triazine moiety, the method comprising: reacting the 1,3,5-hexahydro-1,3,5-triazine moiety in the presence of a Michael donor under conditions selected to yield mono-substituted and di-substituted 1,3,5-hexahydro-1,3,5-triazine resin present in a combined amount that is greater than a combined amount of tri-substituted 1,3,5-hexahydro-1,3,5-triazine and unreacted 1,3,5-hexahydro-1,3,5-triazine moiety; wherein the Michael donor is a thiol. 14. The method of claim 13 , wherein the mono- and di-substituted 1,3,5-hexahydro-1,3,5-triazine resins, respectively, have the following general formula: wherein X is H or CH 3 , R is CH 2 CH 2 —Y, Y is —SR′; and R′ is a linear or branched linear alkyl having 1 to 18 carbon atoms with or without functional groups. 15. The method of claim 14 , wherein R′ is of the general form R′—Z m , wherein m=1-3 and Z═—OH, —SH, —COOH, COOR′, —OPO(OH) 2 , —OPO(OR′)(OH), —PO(OH) 2 , —PO(OR′)(OH), —OSO 2 (OH), aromatics, or substituted aromatics. 16. The method of claim 9 , wherein the mono- and di-substituted 1,3,5-hexahydro-1,3,5-triazine resins, respectively, have the following general formula: wherein X is H or CH 3 , R is CH 2 CH 2 —Y, and Y is imidazole. 17. The method of claim 9 , wherein the hydrolytically-stable, water-soluble polymerizable resin comprises at least one acrylamide group.

Assignees

Inventors

Classifications

  • Compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds · CPC title

  • having no double bonds between ring members or between ring members and non-ring members · CPC title

  • each of the hetero rings containing nitrogen as ring hetero atom · CPC title

  • Six-membered rings · CPC title

  • C07D251/04Primary

    having no double bonds between ring members or between ring members and non-ring members · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US9944611B2 cover?
Disclosed herein are methods of making polymerizable resins containing a 1,3,5-hexahydro-1,3,5-triazine moiety and dental compositions comprising such novel hydrolytically-stable, polymerizable resins derived from a 1,3,5-hexahydro-1,3,5-triazine.
Who is the assignee on this patent?
Dentsply Sirona Inc
What technology area does this patent fall under?
Primary CPC classification C07D251/04. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Apr 17 2018 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 1 related publication on this page (citations in our corpus or others sharing the same primary CPC).